Helling Britney A, Gerber Anthony N, Kadiyala Vineela, Sasse Sarah K, Pedersen Brent S, Sparks Lenore, Nakano Yasushi, Okamoto Tsukasa, Evans Christopher M, Yang Ivana V, Schwartz David A
1 Department of Medicine, School of Medicine, University of Colorado-Denver, Denver, Colorado.
2 Department of Medicine, National Jewish Health, Denver, Colorado; and.
Am J Respir Cell Mol Biol. 2017 Jul;57(1):91-99. doi: 10.1165/rcmb.2017-0046OC.
The gain-of-function mucin 5B (MUC5B) promoter variant, rs35705950, confers the largest risk, genetic or otherwise, for the development of idiopathic pulmonary fibrosis; however, the mechanisms underlying the regulation of MUC5B expression have yet to be elucidated. Here, we identify a critical regulatory domain that contains the MUC5B promoter variant and has a highly conserved forkhead box protein A2 (FOXA2) binding motif. This region is differentially methylated in association with idiopathic pulmonary fibrosis, MUC5B expression, and rs35705950. In addition, we show that this locus binds FOXA2 dynamically, and that binding of FOXA2 is necessary for enhanced expression of MUC5B. In aggregate, our findings identify novel targets to regulate the expression of MUC5B.
功能获得性黏蛋白5B(MUC5B)启动子变体rs35705950赋予特发性肺纤维化发生的最大风险,无论该风险是遗传性的还是其他方面的;然而,MUC5B表达调控的潜在机制尚未阐明。在此,我们鉴定出一个关键调控域,其包含MUC5B启动子变体且具有高度保守的叉头框蛋白A2(FOXA2)结合基序。该区域与特发性肺纤维化、MUC5B表达及rs35705950相关联而发生差异甲基化。此外,我们表明该基因座动态结合FOXA2,且FOXA2的结合对于MUC5B的增强表达是必要的。总体而言,我们的研究结果确定了调控MUC5B表达的新靶点。